399 related articles for article (PubMed ID: 15814741)
41. Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas(lpr) mice.
Feeney AJ; Lawson BR; Kono DH; Theofilopoulos AN
J Immunol; 2001 Sep; 167(6):3486-93. PubMed ID: 11544342
[TBL] [Abstract][Full Text] [Related]
42. Rapid T cell receptor modulation accompanies lack of in vitro mitogenic responsiveness of double negative T cells to anti-CD3 monoclonal antibody in MRL/Mp-lpr mice.
Davignon JL; Cohen PL; Eisenberg RA
J Immunol; 1988 Sep; 141(6):1848-54. PubMed ID: 3262641
[TBL] [Abstract][Full Text] [Related]
43. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu.
Divekar AA; Dubey S; Gangalum PR; Singh RR
J Immunol; 2011 Jan; 186(2):924-30. PubMed ID: 21149603
[TBL] [Abstract][Full Text] [Related]
44. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals.
Dubey C; Croft M; Swain SL
J Immunol; 1996 Oct; 157(8):3280-9. PubMed ID: 8871622
[TBL] [Abstract][Full Text] [Related]
45. Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by
Matsuo T; Hashimoto M; Sakaguchi S; Sakaguchi N; Ito Y; Hikida M; Tsuruyama T; Sakai K; Yokoi H; Shirakashi M; Tanaka M; Ito H; Yoshifuji H; Ohmura K; Fujii T; Mimori T
J Immunol; 2019 Jun; 202(11):3161-3172. PubMed ID: 31019063
[TBL] [Abstract][Full Text] [Related]
46. Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus.
Liu L; Takeda K; Akkoyunlu M
Front Immunol; 2020; 11():1569. PubMed ID: 32849532
[TBL] [Abstract][Full Text] [Related]
47. Intrinsic Differences in Donor CD4 T Cell IL-2 Production Influence Severity of Parent-into-F1 Murine Lupus by Skewing the Immune Response Either toward Help for B Cells and a Sustained Autoantibody Response or toward Help for CD8 T Cells and a Downregulatory Th1 Response.
Soloviova K; Puliaiev M; Haas M; Dalgard CL; Schaefer BC; Via CS
J Immunol; 2015 Oct; 195(7):2985-3000. PubMed ID: 26320249
[TBL] [Abstract][Full Text] [Related]
48. Spontaneous B cell hyperactivity in autoimmune-prone MRL mice.
Nijnik A; Ferry H; Lewis G; Rapsomaniki E; Leung JC; Daser A; Lambe T; Goodnow CC; Cornall RJ
Int Immunol; 2006 Jul; 18(7):1127-37. PubMed ID: 16735376
[TBL] [Abstract][Full Text] [Related]
49. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response.
Dubey C; Croft M; Swain SL
J Immunol; 1995 Jul; 155(1):45-57. PubMed ID: 7541426
[TBL] [Abstract][Full Text] [Related]
50. Autoreactive T cells from MRL-lpr/lpr mice secrete multiple lymphokines and induce the production of IgG anti-DNA antibodies.
Deusch K; Fernandez-Botran R; Konstadoulakis M; Baur K; Schwartz RS; Madaio MP
J Autoimmun; 1991 Aug; 4(4):563-76. PubMed ID: 1777009
[TBL] [Abstract][Full Text] [Related]
51. CD45-associated protein promotes the response of primary CD4 T cells to low-potency T-cell receptor (TCR) stimulation and facilitates CD45 association with CD3/TCR and lck.
Leitenberg D; Falahati R; Lu DD; Takeda A
Immunology; 2007 Aug; 121(4):545-54. PubMed ID: 17428310
[TBL] [Abstract][Full Text] [Related]
52. CD4+ T cells from (New Zealand Black x New Zealand White)F1 lupus mice and normal mice immunized against apoptotic nucleosomes recognize similar Th cell epitopes in the C terminus of histone H3.
Fournel S; Neichel S; Dali H; Farci S; Maillère B; Briand JP; Muller S
J Immunol; 2003 Jul; 171(2):636-44. PubMed ID: 12847228
[TBL] [Abstract][Full Text] [Related]
53. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
[TBL] [Abstract][Full Text] [Related]
54. CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB x NZW)F1 lupus-prone mice: phenotype and possible role in autoreactivity.
Lettesjö H; Burd GP; Mageed RA
J Immunol; 2000 Oct; 165(7):4095-104. PubMed ID: 11034421
[TBL] [Abstract][Full Text] [Related]
55. Langerhans Cells Maintain Local Tissue Tolerance in a Model of Systemic Autoimmune Disease.
King JK; Philips RL; Eriksson AU; Kim PJ; Halder RC; Lee DJ; Singh RR
J Immunol; 2015 Jul; 195(2):464-76. PubMed ID: 26071559
[TBL] [Abstract][Full Text] [Related]
56. B and T cell tolerance and autoimmunity in autoantibody transgenic mice.
Yan J; Mamula MJ
Int Immunol; 2002 Aug; 14(8):963-71. PubMed ID: 12147633
[TBL] [Abstract][Full Text] [Related]
57. Apoptosis defects analyzed in TcR transgenic and fas transgenic lpr mice.
Mountz JD; Zhou T; Bluethmann H; Wu J; Edwards CK
Int Rev Immunol; 1994; 11(4):321-42. PubMed ID: 7528763
[TBL] [Abstract][Full Text] [Related]
58. Differential T cell receptor-mediated signaling in naive and memory CD4 T cells.
Farber DL; Acuto O; Bottomly K
Eur J Immunol; 1997 Aug; 27(8):2094-101. PubMed ID: 9295050
[TBL] [Abstract][Full Text] [Related]
59. The central and multiple roles of B cells in lupus pathogenesis.
Chan OT; Madaio MP; Shlomchik MJ
Immunol Rev; 1999 Jun; 169():107-21. PubMed ID: 10450512
[TBL] [Abstract][Full Text] [Related]
60. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
